RxDoctor Payments Data

Shelby Pitts, NP

Nurse Practitioner · Brigham City, UTNPI 1679079784

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,911 of the $4,723 with a category attached, or 82.8%. It is spread thinly across 42 manufacturers, the largest accounting for just 21.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,078 and has fallen 68.5% since, to $655 in 2025. Among nurse practitioner clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,723in general payments, 2019–2025

Across 241 payments — averaging $19.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Biohaven Pharmaceuticals, Inc.$885
  • AstraZeneca$658
  • Amgen$299
  • Amarin Pharma, Inc.$277
  • Abbott$238
  • plus $1K from 36 others

What the payments were for

  • Consulting fees$80017%
  • Food & beverage$3,91183%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,723 in reported general payments places this provider in the 95th percentile of 979 nurse practitioner providers in Utah.

See all nurse practitioner providers in Utah

Medicare billing

Part B allowed, 2024
$24,232
Medicare patients
104
Services billed
360

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide25$24,272
Levothyroxine Sodium122$1,485
Duloxetine Hcl29$951
Losartan Potassium62$940
Atorvastatin Calcium55$812
Celecoxib36$730
Fluticasone Propionate28$646
Bupropion XlBupropion Hcl25$638
FenofibrateFenofibrate,micronized15$579
Omeprazole38$532
Montelukast Sodium30$471
Rosuvastatin Calcium25$461
Hydroxyzine Hcl18$345
Pregabalin16$344
Potassium Chloride28$322

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$129$24,27225 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 979 nurse practitioner providers in Utah.

Other nurse practitioner in Brigham City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →